Coexpression of multiple predictive markers within the same immune subset suggests that key immune populations (e.g., PD-1+CD27+ T cells or HLA-DRhiCD44+ MDMs) may be critical drivers of immunity within the periventricular tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.